Quantcast

Latest pharmaceutical industry Stories

2014-07-21 23:08:40

The LMCP-100 Extreme Laser by PhotoScribe Technologies marks pills at record-breaking speed. New York, NY (PRWEB) July 21, 2014 PhotoScribe Technologies, the global leader in the manufacturing of laser systems, has impressed the pharmaceutical industry by developing the fastest laser for micro-marking pills on the fly. Marking at speeds exceeding 410,000 pills per hour, the efficiency of the laser’s marking operation reduces both cost and down time for companies looking to increase...

2014-07-21 23:07:11

AstraZeneca Joins NTOCC Partners Council in Collaboration on Transitions of Care Solutions Washington, D.C. (PRWEB) July 21, 2014 The National Transitions of Care Coalition (NTOCC), an organization dedicated to improving patient transitions throughout the healthcare system, is pleased to welcome another member to its Partners Council. AstraZeneca, a global innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription...

2014-07-21 23:06:38

GIA initiates research coverage on the global “Pediatric Drugs and Vaccines” market, as part of its ongoing multiple research projects on diverse industries and markets. The soon to be released report identifies rising incidence of metabolic conditions, cardiovascular and CNS diseases among children, rising per capita healthcare spends in emerging markets and a strong drug development pipeline, as primary growth drivers in the market. San Jose, California (PRWEB) July 21, 2014 Follow...

2014-07-21 16:26:17

SAN FRANCISCO and DUBLIN, July 21, 2014 /PRNewswire/ -- Medicines360, a non-profit women's health pharmaceutical company, and Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Medicines360's New Drug Application (NDA) for Levosert(TM) (levonorgestrel), a hormonal intrauterine contraceptive (IUC) for use by women to prevent pregnancy. In June 2013, Medicines360 and...

2014-07-21 12:25:35

SAN ANTONIO, July 21, 2014 /PRNewswire-USNewswire/ -- ADB International Group Inc.: OTCQB: ADBI (ADBI or the Company) today announced a partnership with Austen BioInnovation Institute in Akron (ABIA or the Institute), for the purpose of bringing ADBI's E-QURE BST(TM), a bioelectrical signal therapy device (the E-QURE BST Device), to the U.S. market. The Institute, which has significant expertise in wound healing, clinical trial development and regulatory operations, will conduct a...

2014-07-21 12:25:25

PORTLAND, Oregon, July 21, 2014 /PRNewswire/ -- A new report by Allied Market Research titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer...

2014-07-21 12:25:16

ALBANY, New York, July 21, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," the global microfluidic device market was valued at USD 3,005 million in 2014 and is expected to grow at a CAGR of 13.8% from 2014 to 2020, to reach an estimated value of USD 6,515.3 million in 2020. Browse the full E-Clinical...

2014-07-20 23:01:11

KRS Global Biotechnology, Inc., an FDA registered and inspected 503B Human Outsourcing Facility that specializes in the preparation of drugs no longer commercially available or in short supply, announces today that they are providing the service of compounded nitroglycerin. Boca Raton, FL (PRWEB) July 20, 2014 KRS Global Biotechnology, Inc. is pleased to announce that it is providing the compounding service of nitroglycerin. Aside from authorized international shipments of the drug into...

2014-07-20 23:00:10

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries and its adoption rate in Europe and North America is very high - http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html. (PRWEB) July 21, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...

2014-07-18 23:01:05

In May 2014, the FDA released a draft guidance that covers the selection and approval process for proposed names of both prescription and nonprescription human drugs and biologics. FDAnews has teamed with drug-naming expert Dr. Susan Proulx to present a 90-minute webinar that will look closely at the draft guidance and its recommended 4-step process. Falls Church, VA (PRWEB) July 18, 2014 Choosing the Right Drug Name: How to Increase Your Chances for Approval **FDAnews Webinar** July...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related